Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Extravasation × Razoxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 5 Sarcoma 3 Lymphoma 3 Sarcoma, Synovial 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leukemia 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Fibrosarcoma 1 Extravasation 1 Dermatofibrosarcoma 1

Interventions

Razoxane 1 Dexrazoxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00548704 2015-10-21

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed

Extravasation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡